Key result
Endothelial dysfunction (NO <36.0 μmol/L) and creatinine ≥73.0 μmol/L were associated with coronary and carotid atherosclerosis, while low HDL-C and CRP ≥1.0 mg/L marked severe disease.
Why the study?
To identify and characterize associations between circulating biochemical parameters and the presence and severity of atherosclerosis across various vascular beds, and to assess their potential as markers of metabolic disorders.
Observational (n=216)
Specific circulating biomarkers, including NO metabolites, creatinine, HDL-C, CRP, glucose, and insulin, correlate with the localization and severity of atherosclerosis across different vascular beds.
These associations should not change practice; leaves open whether biomarkers predict atherosclerosis progression or outcomes.
Aim. To identify and characterize the associations of the presence and severity of atherosclerosis of various localization with the blood level of biochemical parameters, as well as to assess the potential of their use as markers of metabolic disorders with increased atherogenic potential. Material and methods . The study included 216 patients (men, 53%) aged 24-87 years (mean age, 61,5±10,73 years). All patients underwent coronary angiography, carotid (CA) and femoral arterial (FA) duplex ultrasound to assess the presence and severity of atherosclerosis. In blood serum/plasma, biochemical parameters were analyzed using standard methods. Results. Based on the analysis of circulating biomarker profile, diagnostic complexes have been established that allow assessing atherosclerosis of different localization. According to the data obtained, the determinants of coronary and CA atherosclerosis are endothelial dysfunction (concentration of nitric oxide metabolites <36,0 μmol/L) and an increased level of creatinine (≥73,0 μmol/L). The specific markers associated with severe atherosclerosis of coronary and FAs (but not CA) were low high-density lipoprotein cholesterol (≤1,0/1,2 μmol/L for male/ female, respectively) and an increased C-reactive protein level (≥1,0 mg/l). Severe peripheral atherosclerosis (CA and FA involvement) was associated with hyperglycemia (glucose ≥6,1 μmol/L), while severe FA atherosclerosis — with hyperinsulinemia (insulin ≥14,0 μU/ml). Conclusion. The analysis of associations of circulating biochemical parameters with atherosclerosis localization and severity revealed a number of metabolic markers associated with the increased atherogenic potential. It is possible to distinguish both universal parameters that are associated with atherosclerosis, regardless of its localization and/or severity, and specific biomarkers that characterize either the localization or the severity of atherosclerosis, or both.
No takes yet. Share an insight, caveat, or question.
Metelskaya et al. (2022) conducted an observational in Atherosclerosis (n=216). Circulating biomarkers was evaluated on Presence and severity of atherosclerosis of various localization. Endothelial dysfunction (NO <36.0 μmol/L) and creatinine ≥73.0 μmol/L were associated with coronary and carotid atherosclerosis, while low HDL-C and CRP ≥1.0 mg/L marked severe disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: